Ghost Tree Capital, LLC Coherus Bio Sciences, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$14.43 - $19.16 $2.16 Million - $2.87 Million	-150,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $3.27 Million - $6.31 Million	-280,000 Reduced 65.12%	150,000 $2.43 Million
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $7.02 Million - $9.19 Million	430,000 New	430,000 $7.74 Million
Q3 2019 Nov 14, 2019	SELL	$16.3 - $23.37 $2.85 Million - $4.09 Million	-175,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$13.1 - $22.1 $3.6 Million - $6.08 Million	-275,000 Reduced 61.11%	175,000 $3.87 Million
Q1 2019 May 15, 2019	BUY	$8.38 - $15.5 $3.77 Million - $6.98 Million	450,000 New	450,000 $6.14 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.